Impact of Disease Duration on the Effects of Pramlintide in Type 1 Diabetes: A Post Hoc Analysis of Three Clinical Trials.
about
Weight Management in Patients with Type 1 Diabetes and Obesity.Efficacy and safety of pramlintide injection adjunct to insulin therapy in patients with type 1 diabetes mellitus: a systematic review and meta-analysis.Optimization of tolerability and efficacy of the novel dual amylin and calcitonin receptor agonist KBP-089 through dose escalation and combination with a GLP-1 analog.Pharmacological Treatment in Diabetes Mellitus Type 1 - Insulin and What Else?
P2860
Impact of Disease Duration on the Effects of Pramlintide in Type 1 Diabetes: A Post Hoc Analysis of Three Clinical Trials.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Impact of Disease Duration on ...... ysis of Three Clinical Trials.
@en
type
label
Impact of Disease Duration on ...... ysis of Three Clinical Trials.
@en
prefLabel
Impact of Disease Duration on ...... ysis of Three Clinical Trials.
@en
P2093
P2860
P1433
P1476
Impact of Disease Duration on ...... lysis of Three Clinical Trials
@en
P2093
David G Maggs
Kathrin Herrmann
Steven C Brunell
P2860
P2888
P304
P356
10.1007/S12325-016-0326-5
P407
P50
P577
2016-04-12T00:00:00Z